Who
Boekhorst Paul Francis Olivier te
President and CEO
Company insider
Files Form 4 as: President and CEO, ImmuCell.
In numbers
- Trades disclosed
- 12
- Buys
- 5
- Sells
- 0
- Bought
- $232K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 7 Nov 2025
- Last trade
- 18 Jun 2026
- Last filed
- 22 Jun 2026
Companies traded
Activity over time
1 Dec 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 18 Jun 2026filed 22 Jun 2026 | ICCC ImmuCellDiagnostics & Labs | SEC FORM 4 Bought | $76K8,000 at $9.50 | filing |
| 18 Jun 2026filed 22 Jun 2026 | ICCC ImmuCellDiagnostics & Labs | SEC FORM 4 Bought | $76K8,000 at $9.50 | filing |
| 27 Jan 2026filed 23 Mar 2026 | ICCC ImmuCelloption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —109,500 at $0.00 | filing |
| 27 Jan 2026filed 23 Mar 2026 | ICCC ImmuCelloption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —109,500 at $0.00 | filing |
| 27 Jan 2026filed 29 Jan 2026 | ICCC ImmuCelloption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —110,000 at $0.00 | filing |
| 27 Jan 2026filed 29 Jan 2026 | ICCC ImmuCelloption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —110,000 at $0.00 | filing |
| 4 Dec 2025filed 4 Dec 2025 | ICCC ImmuCellDiagnostics & Labs | SEC FORM 4 Bought | $13K2,432 at $5.50 | filing |
| 3 Dec 2025filed 4 Dec 2025 | ICCC ImmuCellDiagnostics & Labs | SEC FORM 4 Bought | $18K3,598 at $5.05 | filing |
| 3 Dec 2025filed 3 Dec 2025 | ICCC ImmuCellDiagnostics & Labs | SEC FORM 4 Bought | $13K2,556 at $5.00 | filing |
| 3 Dec 2025filed 3 Dec 2025 | ICCC ImmuCellDiagnostics & Labs | SEC FORM 4 Bought | $18K3,521 at $5.04 | filing |
| 2 Dec 2025filed 3 Dec 2025 | ICCC ImmuCellDiagnostics & Labs | SEC FORM 4 Bought | $18K3,708 at $4.87 | filing |
| 7 Nov 2025filed 12 Nov 2025 | ICCC ImmuCelloption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | $453K74,277 at $6.10 | filing |
News
ImmuCell Announces a 46% Increase in Product Sales in Quarter Three of 2026, Based on Preliminary, Unaudited Sales ResultsICCC · manilatimes.net · 12 Oct 2026
0 headlines in the last 90 days name Boekhorst Paul Francis Olivier te; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.